Palliative chemotherapy with cisplatin (C) and ifosfamide (I) for recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

被引：0
|
作者：
Fernández, A [1 ]
Mesía, R [1 ]
Montes, A [1 ]
Cardenal, F [1 ]
Montes, A [1 ]
García, M [1 ]
Dotor, E [1 ]
Muñoz, M [1 ]
Juan, A [1 ]
Monner, A [1 ]
Galiana, R [1 ]
机构：
[1] CSUB Hosp, Dept Med Oncol, Inst Catala Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [41] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck
    Huber, MH
    Lippman, SM
    Benner, SE
    Shirinian, M
    Dimery, IW
    Dunnington, JS
    Hong, WK
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (04): : 379 - 383
  • [43] The role of cetuximab maintenance after chemotherapy in patients with recurrent/metastatic squamous cell carcinoma of head and neck (R/M SCCHN): A retrospective analysis
    Wakasugi, T.
    Enokida, T.
    Nakanome, A.
    Yamazaki, T.
    Okano, S.
    Tahara, M.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 95 - 95
  • [44] Induction Chemotherapy with Cisplatin, Paclitaxel, and Capecitabine (PTC) in Locally Advanced (LA) Squamous Cell Carcinoma of Head and Neck (SCCHN)
    Alvarado-Munoz, J. F.
    Reyes-Morales, A.
    Puac-Polanco, V.
    Bruixola, G.
    Chivalan, M.
    Torselli, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E26 - E26
  • [45] CHEMOTHERAPY OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    PERRY, MC
    DAVIDSON, EM
    KARDINAL, CG
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 479 - 479
  • [46] Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis
    Bahl, Ankur
    Bhatia, Komal
    Choudhary, Pragati
    Singhla, Suhas
    Shrivastava, Gunjan
    Bal, Jaspriya
    Anand, Anil K.
    Chaturvedi, Harit M. Ch
    Dua, Bharat
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (05): : 955 - 962
  • [47] Future perspectives in the treatment of chemotherapy and radiotherapy for squamous cell carcinoma of the head and neck (SCCHN)
    Herchenhorn, D
    [J]. 2ND WORLD CONGRESS OF THE INTERNATIONAL FEDERATION OF HEAD AND NECK ONCOLOGIC SOCIETIES, 2002, : 39 - 50
  • [48] Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN)
    Kies M.S.
    [J]. Current Treatment Options in Oncology, 2007, 8 (3) : 252 - 260
  • [49] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    [J]. CANCER, 2001, 91 (07) : 1316 - 1323
  • [50] Preliminary report of phase II study of neoadjuvant chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in locally advanced squamous cell carcinoma of the head and neck cancer (SCCHN) patients
    Chitapanarux, I.
    Lorvidhaya, V.
    Tharavichitkul, E.
    Sittitrai, R.
    Pattarasakulchai, I.
    Kamnerdsupaphon, P.
    Sukthomyal, V.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 311 - 312
12345